Prevalence, types and disclosure of complementary and alternative medicine (CAM) use among chronic kidney disease (CKD) patients in Saudi Arabia

Journal of Pharmaceutical Policy and Practice

Research

Imen Ben Abdelmalek¹  Ghada Ben Salah²  Muhammad Kamran Rasheed³  Nada Ibrahim⁴  Abir Elghazali⁴  Lamyaa Kassem⁴  Maryam Farooqui⁴  Mohammed Salem Alshammari⁴ 

[1] Department of Biology, College of Science, Qassim University, 52571, Buraydah, Saudi Arabia;Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, 52571, Buraydah, Saudi Arabia;Department of Pharmacy Practice, College of Pharmacy, Qassim University, 52571, Buraydah, Saudi Arabia;Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, 52571, Buraydah, Saudi Arabia;

关键词: Complementary and alternative medicines;    Chronic kidney disease;    Treatment;    Chronic disease;    Cross-sectional studies;    Health surveys;    Public health;    Adverse event;    Saudi Arabia;   

DOI  :  10.1186/s40545-023-00589-2

 received in 2023-05-21, accepted in 2023-06-22,  发布年份 2023

来源: Springer

【 摘 要 】

IntroductionDespite the paucity of scientific evidence, CAM is widely used for the prevention and treatment of illness among patients with chronic kidney disease, including end-stage renal disease and kidney transplant recipients. It is evident that the irrational use of CAM among CKD patients and its non-disclosure to healthcare providers could lead to adverse drug events. Hence, the current study was conducted to evaluate the prevalence, types, and non-disclosure of CAM use among CKD patients and kidney transplant recipients in Saudi Arabia.MethodsA cross-sectional study was conducted on 170 CKD patients (121 with stages 3 and 4, two with stage 5 and on hemodialysis, and 47 kidney transplant recipients). Face-to-face questionnaire-based interviews were conducted employing a convenience sampling technique. The study outcomes were the prevalence of CAM, types of CAM use, monthly expenditure on CAM, the source of information about CAM, and CAM disclosure to healthcare providers. A p-value of < 0.05 was considered significant.ResultsThe study found that out of 170, 60 (35.3%) CKD patients use CAM. The most used CAM was Acacia gum (49, 81.6%) followed by spiritual therapies (34, 56.6%). Female CKD patients had higher use of CAM compared to the male gender (p = 0.015). The monthly expenditures that most users (47, 78.3%) spent on CAM were less than 50 Saudi Riyals (SR). The study results also showed that 55% of CKD patients did not report their CAM use to their physicians. Furthermore, 46.6% of CAM users discontinue their use of CAM after observing no benefit.ConclusionThis study reported relatively high use of CAM among CKD patients in Saudi Arabia. The study found that most CKD patients use Acacia gum and spiritual therapies and do not disclose the use of CAM to healthcare professionals, which could lead to adverse drug events. Therefore, the study recommends that healthcare providers should inquire and provide evidence-based counselling about the use of CAM to CKD patients to prevent any adverse drug event or unwanted effect on the renal function of the patients.

【 授权许可】

CC BY   
© The Author(s) 2023